MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$14,964,875
Net loss
-$14,964,875
Interest income
$415,831
Loss from operations
-$15,380,706
Total operating
expenses
$15,380,706
Research and development
$10,867,983
General and
administrative
$4,505,406
Amortization of intangible
asset
$7,317
Back
Back
Income Statement
source: myfinsight.com
Immuneering Corp (IMRX)
Immuneering Corp (IMRX)